Document is current
Any future updates will be listed below
-
Authors
Leishman, Emma
Wang, Yizhong
Channu, Reddy
Boyst, Evan
Hartmann, Marshall
Stas, Justin
- License Information
-
More Information
Article History
Received: 30 September 2020
Accepted: 21 December 2020
First Online: 13 January 2021
Competing interests
: The work describes a patented formulation, held by Okra Medical (US patent ID 10668312). JS, YW, RC, EB, and EL are co-inventors on the patent. MH and JS are CEO and CTO of Okra Medical, respectively. Avomeen (employer of EL, YW, RC, and EB) received funding from Okra Medical to perform the research.
